With optimal treatment, myeloma isn't immediately life-threatening. Many patients live for years after their diagnosis, often ...
Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize ...
In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR ...
A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." Researchers Andrea ...
Multiple myeloma is a serious but often misunderstood disease. It affects thousands of people every year, including many in Black communities, where the risk is nearly twice as high as ...
Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load There is consensus that patients with light ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell ...
One year ago, Joan, my wife of 58 years, died of complications related to multiple myeloma, a blood cancer that can often go undiagnosed until it begins to seriously damage one’s health, as it ...
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that ...
Over the years, Myeloma Action Month (MAM) has been dedicated to raising awareness and inspiring action within the myeloma community. It has grown to become a global effort, reaching over 60 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results